These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11267238)

  • 1. Matching does not improve outcome from aged marginal kidney donors.
    Alfrey EJ; Lu AD; Carter JT; Dafoe DC
    Transplant Proc; 2001; 33(1-2):1162-3. PubMed ID: 11267238
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of donor/recipient gender, age, HLA matching, and weight on short-term graft survival following living related renal transplantation.
    Shaheen FA; al Sulaiman M; Mousa D; el Din AB; Hawas F; Fallatah A; Bill P; Sheikh IA; al Menawy L; Ramprasad KS; al-Khader AA
    Transplant Proc; 1998 Nov; 30(7):3655-8. PubMed ID: 9838603
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of delayed graft function on graft survival in living donor kidney transplantation.
    Kwon OJ; Ha MK; Kwak JY; Lee HW
    Transplant Proc; 2003 Feb; 35(1):92-3. PubMed ID: 12591321
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of donor age on long-term graft survival in living donor kidney transplantation.
    Kanematsu A; Tanabe K; Ishikawa N; Tokumoto T; Huchinoue S; Takahashi K; Toma H
    Transplant Proc; 1998 Nov; 30(7):3118-9. PubMed ID: 9838377
    [No Abstract]   [Full Text] [Related]  

  • 5. Flow cytometry crossmatch and kidney graft outcome.
    Piazza A; Borrelli L; Buonomo O; Pisani F; Valeri M; Torlone N; Felici A; Monaco PI; Adorno D; Casciani CU
    Transplant Proc; 1999; 31(1-2):314-6. PubMed ID: 10083123
    [No Abstract]   [Full Text] [Related]  

  • 6. Omit HLA matching to attain shorter cold ischemic time?
    Aswad S; Mann SL; Khetan U; Asai P; Bogaard T; Mendez RG; Mendez R
    Transplant Proc; 1993 Dec; 25(6):3053-5. PubMed ID: 8266450
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of early predictors of renal transplantation results.
    Cantarovich F; Carbajal R; Medioni J; Marmol A; Morelon E; Landais P
    Transplant Proc; 2001; 33(1-2):1192-3. PubMed ID: 11267253
    [No Abstract]   [Full Text] [Related]  

  • 8. Sharing 0-antigen mismatched cadaveric kidneys does not decrease the graft survival of payback kidneys.
    Stegall MD; McBride M; Wynn J
    Transplant Proc; 2001; 33(1-2):920-1. PubMed ID: 11267129
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed graft function influences renal function but not survival.
    Boom H; Mallat MJ; de Fijter JW; Zwinderman AH; Paul LC
    Transplant Proc; 2001; 33(1-2):1291. PubMed ID: 11267296
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival and function of a renal graft from a marginal cadaver donor.
    Pokorná E; Vítko S; Chadimová M
    Transplant Proc; 1997; 29(1-2):118-21. PubMed ID: 9122922
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of HLA compatibility, pregnancies, blood transfusions, and taboo mismatches in living unrelated kidney transplantation.
    Poli L; Pretagostini R; Rossi M; Novelli G; Berloco P; Iappelli M; Casciaro G; De Blasis V; Colonnello M; Cancrini C; Peritore D; Cortesini R
    Transplant Proc; 2001; 33(1-2):1136-8. PubMed ID: 11267225
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of donors age on graft survival in renal transplanted children.
    Adams J; Tönshoff B; Staehler G; Wiesel M
    Transplant Proc; 2001 Sep; 33(6):2973-4. PubMed ID: 11543816
    [No Abstract]   [Full Text] [Related]  

  • 13. Early and late impact of a positive flow cytometry crossmatch on graft outcome in primary renal transplant.
    Abou El Fettouh H; Cook DJ; Flechner S; Goldfarb D; Gill I; Modlin C; Dennis V; Novick AC
    Transplant Proc; 2001 Sep; 33(6):2968-70. PubMed ID: 11543814
    [No Abstract]   [Full Text] [Related]  

  • 14. The relevance of HLA A,B,C, matching on graft survival, patient survival, and graft function in living related renal transplant patients treated with cyclosporine.
    Masri MA; Dhawan IK; Hayes K; Zahir M; Shanwaz M; Shakuntala S; Pingle A
    Transplant Proc; 1992 Oct; 24(5):1676-7. PubMed ID: 1412793
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplant recipients with graft survival longer than 20 years: report on 107 cases.
    Kyllönen L; Koskimies S; Salmela K
    Transplant Proc; 2001 Jun; 33(4):2444-5. PubMed ID: 11406203
    [No Abstract]   [Full Text] [Related]  

  • 16. Cadaveric renal transplantation from non-heart-beating donors with graft survival for more than 10 years.
    Yoshida K; Endo T; Saito T; Ikeda M; Kamata K; Baba S
    Transplant Proc; 2002 Nov; 34(7):2604-7. PubMed ID: 12431541
    [No Abstract]   [Full Text] [Related]  

  • 17. One or two marginal organs for kidney transplantation?
    Perico N; Ruggenenti P; Scalamogna M; Locatelli G; Remuzzi G
    Transplant Proc; 2002 Dec; 34(8):3091-6. PubMed ID: 12493384
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors affecting the graft survival in cadaver donor kidney transplantation.
    Chon SE; Lee KW; Joh JW; Kim SJ; Park JH; Lee SK; Oh HY; Huh WS; Kim YI; Lee BB
    Transplant Proc; 2003 Feb; 35(1):147-8. PubMed ID: 12591342
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation.
    Morrissey PE; Gohh RY; Monaco AP
    Transplant Proc; 2002 Aug; 34(5):1640-1. PubMed ID: 12176517
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of acute rejection on long-term graft survival in HLA-identical living-related kidney transplants.
    Al-Kerithy M; Salazar A; Kiberd B; Bitter-Suermann H; MacDonald AS; Lawen JG
    Transplant Proc; 2001 Sep; 33(6):2982-3. PubMed ID: 11543820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.